4//SEC Filing
Cannon Gillian 4
Accession 0000950170-25-083318
CIK 0001582313other
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 5:57 PM ET
Size
7.4 KB
Accession
0000950170-25-083318
Insider Transaction Report
Form 4
Cannon Gillian
Director
Transactions
- Award
Share Option (Right to Buy)
2025-06-05+17,012→ 17,012 totalExercise: $30.73Exp: 2035-06-04→ Common Shares (17,012 underlying) - Award
Restricted Share Units
2025-06-05+2,645→ 2,645 totalExercise: $0.00→ Common Shares (2,645 underlying)
Footnotes (2)
- [F1]Vesting 100% on the earlier of (i) June 4, 2026 or (ii) the day before the date of the issuer's 2026 annual meeting of shareholders.
- [F2]Each restricted share unit represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 4, 2026 or (ii) the day before the date of the issuer's 2026 annual meeting of shareholders.
Documents
Issuer
Xenon Pharmaceuticals Inc.
CIK 0001582313
Entity typeother
Related Parties
1- filerCIK 0001833910
Filing Metadata
- Form type
- 4
- Filed
- Jun 5, 8:00 PM ET
- Accepted
- Jun 6, 5:57 PM ET
- Size
- 7.4 KB